Medic Vision Imaging Solutions, the leading innovator of vendor-independent solutions for CT and MRI scanners, today announced that it has signed a multi-million dollar partnership agreement with KAME, an affiliate of Beijing Century Galaxy...
Read moreCStone Pharmaceuticals (“CStone”) today announced that the National Medical Products Administration (NMPA) recently approved a Phase III clinical trial in China for its partnered drug candidate avapritinib as a third-line treatment...
Read moreCStone Pharma, a Suzhou oncology company, plans to raise $304 million in its Hong Kong IPO at a valuation of $1.5 billion. Even though CStone is just two and one-half years-old, it has 14 oncology programs underway, including nine in clinical or...
Read moreChemspace and LabNetwork, a WuXi AppTec company, both online marketplaces for chemical compounds used in drug discovery, today announced they have entered into a collaboration agreement. Under the agreement, LabNetwork’s products will be...
Read moreOn February 14, 2019, Burning Rock held the signing ceremony and announced the closing of the Series C financing totaling RMB 850 million. The financing was led by GIC, followed by LYFE Capital, CMB International Capital, Lilly Asia Ventures...
Read moreNanjing Bioheng Biotech completed a $15 million Series A financing, with all of the funds invested by Decheng Capital. Bioheng, which focuses on cell therapy products, is developing a universal CAR-T product that it expects will lower the cost of...
Read moreMevion Medical Systems announced today it has signed a contract with Allcure Kangtai Proton Technology Co., Ltd. in China for the purchase of a MEVION S250i Proton Therapy System® with HYPERSCAN® Pencil Beam Scanning technology in late December...
Read moreChoom™ (CSE: CHOO; OTCQB: CHOOF) is pleased to announce that it has entered into a letter of intent agreement (“LOI”) with one of the 25 Cannabis Retail lottery winners to open a location in Ontario. Choom, an emerging adult use...
Read moreAscletis Pharma Inc. (Ascletis, 1672.HK) and 3-V Biosciences, Inc. (3-V Biosciences) jointly announce today that Ascletis, through its subsidiary, and 3-V Biosciences have entered into an exclusive license agreement for 3-V Biosciences’...
Read moreJohnson & Johnson <JNJ.N> said on Wednesday it would buy Auris Health Inc for $3.4 billion (2.6 billion pounds) in cash, gaining access to the privately held company’s surgical robotic scope used in respiratory procedures and the...
Read moreThe cannabis story is quickly gaining monumental support. All as Congressional support for cannabis legalization grows. Just last week, Democratic Sen. Ron Wyden (OR) introduced S. 420, which seeks to legalize and regulate cannabis on a federal...
Read moreChina will reduce the Value Added Tax on 21 rare disease treatments to 3%, starting March 1. The State Council ordered the cuts on Monday, and said it was also directing drug regulators to speed the approval process for cancer drugs and foreign...
Read more
